Open AccessIntranasal administration of abatacept enhances IL-35+ and IL-10+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model
Author(s) -
Maha Fahad Alenazy,
Fatemeh Saheb SharifAskari,
Mohammad S. ElWetidy,
Narjes Saheb SharifAskari,
Ibrahim Y. Hachim,
MohamadHani Temsah,
Basema Saddik,
Roua Al-Kufaidy,
Maha A. Omair,
Yasser A. Alshawakir,
Amany A. Fathaddin,
Suad Hannawi,
Qutayba Hamid,
Mohammed A. Omair,
Saleh AlMuhsen,
Rabih Halwani
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0271689
Subject(s) - abatacept , ovalbumin , medicine , nasal administration , immunology , inflammation , rheumatoid arthritis , lung , interleukin 10 , asthma , pharmacology , cytokine , immune system , antibody , rituximab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom